National Institute of Allergy and Infectious Diseases announces HIV vaccine initiative awards

"Researchers at 14 institutions will explore new approaches to designing a vaccine against HIV with awards that are part of an anticipated four-year, $34.8 million initiative, the National Institute of Allergy and Infectious Diseases [NIAID] announced [Tuesday]," the Center for Global Health Policy's "Science Speaks" blog reports. "The awards reflect directions suggested by previous research, as well as the need to explore new avenues toward a vaccine, NIAID Director Dr. Anthony Fauci told Science Speaks," the blog writes. "'There are some remaining important facts that we don't know about HIV,' Fauci said," adding, "There are many fundamental questions that remain unanswered," according to the blog. "The awards are intended to allow researchers to ask those questions, he said," the blog notes (Barton, 8/21).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study provides insights into trends and disparities of neonatal infectious diseases in LMICs